Product Name
Ornithine Carbamoyl Transferase (OCT), Polyclonal Antibody
Full Product Name
Polyclonal Antibody to Ornithine Carbamoyl Transferase (OCT)
Product Gene Name
anti-OCT antibody
[Similar Products]
Matching Pairs
Unconjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2007238)
Immunogen: Ornithine Carbamoyl Transferase (OCT) (MBS2009622)
Matching Pairs
Unconjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2007238)
APC-CY7 Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2055853)
Matching Pairs
Unconjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2007238)
PE Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2055854)
Matching Pairs
Unconjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2007238)
APC Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2055855)
Matching Pairs
Unconjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2007238)
Cy3 Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2055856)
Matching Pairs
Unconjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2007238)
FITC Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2055857)
Matching Pairs
Unconjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2007238)
HRP Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2055858)
Matching Pairs
Unconjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2007238)
APC-CY7 Conjugated Secondary Antibody: Immunoglobulin G (MBS2090675)
Matching Pairs
Unconjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2007238)
Unconjugated Secondary Antibody: Immunoglobulin G (MBS2090678)
Matching Pairs
Unconjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2007238)
Biotin Conjugated Antibody: Ornithine Carbamoyl Transferase (OCT) (MBS2093380)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence
Antigen: The target protein is fused with two N-terminal Tags, His-tag and its sequence is listed below.
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEF-QGK SLGMIFEKRS TRTRLSTETG FALLGGHPCF LTTQDIHLGV NESLTDTARV LSSMADAVLA RVYKQSDLDT LAKEASIPII NGLSDLYHPI QILADYLTLQ EHYSSLKGLT LSWIGDGNNI LHSIMMSAAK FGMHLQAATP KGYEPDASVT KLAEQYAKEN GTKLLLTNDP LEAAHGGNVL ITDTWISMGQ EEEKKKRLQA FQGYQVTMKT AKVAASDWTF LHCLPRKPEE VDDEVFYSPR SLVFPEAENR KWTIMAVMVS LL
3D Structure
ModBase 3D Structure for P00480
Specificity
The antibody is a rabbit polyclonal antibody raised against OCT. It has been selected for its ability to recognize OCT in immunohistochemical staining andwestern blotting.
Purity/Purification
Affinity Chromatography
Form/Format
Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3,50% glycerol.
Concentration
200ug/ml (lot specific)
Immunogen
Recombinant OCT (Gln78~Leu342) expressed in E.coli.
Conjugated Antibody
The APC conjugated antibody version of this item is also available as catalog #MBS2055855
Preparation and Storage
Store at 4 degree C for frequent use. Stored at -20 degree C to -80 degree C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
ISO Certification
Manufactured in an ISO 9001:2008 and ISO 13485:2003 Certified Laboratory.
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customera??s specifications, please inquire.
Other Notes
Small volumes of anti-OCT antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Applications Tested/Suitable for anti-OCT antibody
Immunocytochemistry (ICC), Immunohistochemistry (IHC) - Formalin/Paraffin, ELISA (EIA), Western Blot (WB)
Application Notes for anti-OCT antibody
Western blotting: 1:100-400
Immunocytochemistry in formalin fixed cells: 1:100-500
Immunohistochemistry in formalin fixed frozen section: 1:100-500
Immunohistochemistry in paraffin section: 1:50-200
Enzyme-linked Immunosorbent Assay: 1:100-200
Western Blot (WB) of anti-OCT antibody
Western Blot: Sample: Recombinant protein.

Immunohistochemistry (IHC) of anti-OCT antibody
DAB staining on IHC-P; Samples: Human Colorectal cancer Tissue)

NCBI/Uniprot data below describe general gene information for OCT. It may not necessarily be applicable to this product.
NCBI Accession #
NP_000522.3
[Other Products]
NCBI GenBank Nucleotide #
NM_000531.5
[Other Products]
UniProt Primary Accession #
P00480
[Other Products]
UniProt Secondary Accession #
Q3KNR1; Q6B0I1; Q9NYJ5; A8K9P2; D3DWB0[Other Products]
UniProt Related Accession #
P00480[Other Products]
Molecular Weight
39,935 Da
NCBI Official Full Name
ornithine carbamoyltransferase, mitochondrial
NCBI Official Synonym Full Names
ornithine carbamoyltransferase
NCBI Official Symbol
OTC??[Similar Products]
NCBI Official Synonym Symbols
OCTD
??[Similar Products]
NCBI Protein Information
ornithine carbamoyltransferase, mitochondrial
UniProt Protein Name
Ornithine carbamoyltransferase, mitochondrial
UniProt Synonym Protein Names
Ornithine transcarbamylase; OTCase
UniProt Gene Name
OTC??[Similar Products]
UniProt Synonym Gene Names
OTCase??[Similar Products]
NCBI Summary for OCT
This nuclear gene encodes a mitochondrial matrix enzyme. Missense, nonsense, and frameshift mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. Since the gene for this enzyme maps close to that for Duchenne muscular dystrophy, it may play a role in that disease also. [provided by RefSeq, Jul 2008]
UniProt Comments for OCT
OTC: Defects in OTC are the cause of ornithine carbamoyltransferase deficiency (OTCD). OTCD is an X- linked disorder of the urea cycle which causes a form of hyperammonemia. Mutations with no residual enzyme activity are always expressed in hemizygote males by a very severe neonatal hyperammonemic coma that generally proves to be fatal. Heterozygous females are either asymptomatic or express orotic aciduria spontaneously or after protein intake. The disorder is treatable with supplemental dietary arginine and low protein diet. The arbitrary classification of patients into the 'neonatal' group (clinical hyperammonemia in the first few days of life) and 'late' onset (clinical presentation after the neonatal period) has been used to differentiate severe from mild forms. Belongs to the ATCase/OTCase family.
Protein type: Amino Acid Metabolism - arginine and proline; EC 2.1.3.3; Mitochondrial; Transferase
Chromosomal Location of Human Ortholog: Xp11.4
Cellular Component: mitochondrial inner membrane; mitochondrial matrix; mitochondrion
Molecular Function: amino acid binding; ornithine carbamoyltransferase activity; phosphate binding; phospholipid binding
Biological Process: anion homeostasis; arginine biosynthetic process via ornithine; citrulline biosynthetic process; liver development; midgut development; ornithine catabolic process; response to drug; response to insulin stimulus; response to zinc ion; urea cycle
Disease: Ornithine Transcarbamylase Deficiency, Hyperammonemia Due To
Research Articles on OCT
1. In Korean patients with OTC deficiency, mutations in OTC are genetically heterogeneous.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.